基因工程抗体融合蛋白比传统的化学交联的抗体融合蛋白具有更多的优越性。
Genetically engineered antibody fusion proteins have more advantages over traditional chemical crosslinking antibody fusion proteins.
基因工程抗体融合蛋白比传统的化学交联的抗体融合蛋白具有更多的优越性。
Genetically engineered antibody fusion proteins have more advantages over traditional chemical crosslinking antibody fusion prot...
基因工程抗体融合蛋白比传统的化学交联的抗体融合蛋白具有更多的优越性。
Antibody fusion protein can be particularly used to prepare the immuno directed drug. Genetically engineered antibody fusion proteins have more advantages over traditional chemical crosslink...
结果表明，用此融合蛋白的包涵体免疫豚鼠能诱导产生中和抗体，并对病毒的攻击提供免疫保护。
The results showed that the fusion protein can yield antibodies with high neutralizing activity as well as provide protection against challenge with virulent virus.
该单克隆抗体是通过用包含人EGF受体胞质域的融合蛋白免疫动物而制备的。
Monoclonal antibody is produced by immunizing animals with a fusion protein containing the cytoplasmic domain of human EGF receptor.
单克隆抗体通过合成GST融合蛋白免疫动物制备。
Monoclonal antibody is produced by immunizing animals with a GST fusion protein.
呼吸道合胞病毒(RSV)，融合蛋白，克隆号：0631，单克隆抗体。
Respiratory Syncytial Virus (RSV), Fusion Protein, Clone: 0631, Mab anti.
呼吸道合胞病毒（RSV），融合蛋白，克隆号： 0681，单克隆抗体。
Respiratory Syncytial Virus (RSV), Fusion Protein, Clone: 0681, Mab anti.
目的：表达人免疫相关鸟苷三磷酸酶基因(IRGM) a全长融合蛋白，制备高质量的兔抗人IRGM多克隆抗体。
Aim: To express the whole length fusion protein of human IRGMa and prepare high quality rabbit anti-human immune-related gene guanosine triphosphate (IRGM) polyclonal antibody.
单克隆抗体由BMP4融合蛋白免疫动物产生。
Monoclonal antibody is produced by immunizing animals with a BMP4 fusion protein.
包括单克隆抗体、酪氨酸激酶抑制剂、融合蛋白、瘤苗在内，以her2为靶点的抗肿瘤治疗研究成为热点，并显示出广阔的应用前景。
Anticancer therapies targeting HER2 have shown promise and become a focus, including monoclonal antibody, tyrosine kinases inhibitor, tumor vaccine, fusion protein.
目的：MCPR 1是我室利用消减杂交技术克隆出来的新基因，本研究利用融合蛋白制备mcpr1的多克隆抗体。
Objective: To prepare polyclonal antibodies of MCPR1, which is a novel Mouse Cleft Palate Relate gene cloned by subtractive hybridization method at our department.
单克隆抗体由包含人ALK氨基酸1475的重组融合蛋白对动物进行免疫得到。
Monoclonal antibody is produced by immunizing animals with a recombinant fusion protein surrounding amino acid 1475 of human ALK.
摘要：目的在大肠杆菌中表达HZF1融合蛋白，制备抗hzf1抗体。
ABSTRACT: Objective to express human HZF1 fusion protein in E. coli and to obtain an anti-HZF1 antibody.
该单克隆抗体是由重组人cdc2融合蛋白免疫动物而生产的。
Monoclonal antibody is produced by immunizing animals with a recombinant human cdc2 fusion protein.
将表达的融合蛋白作为包被抗原，建立了间接酶联免疫吸附试验(间接elisa)的诊断方法以检测CDV血清抗体水平。
The method of indirect ELISA to detect CDV antibody in blood serum was established, using recombinant nucleocapsid protein as envelope antigen.
以该融合蛋白为固相抗原，对噬菌体抗体库进行3轮淘筛，并对所获阳性克隆进行抗原结合活性测定和DNA序列测定。
Specific antibody was screened by 3 rounds of panning of phage antibody library with the fusion protein. The antigen binding activity and DNA sequences of positive clones were determined and analyzed.
拟获得在大肠杆菌中能高效可溶表达的转铁蛋白受体单链抗体与链亲和素（SA）的重组融合蛋白。
To obtain the anti-transferrin receptor scFv and streptavidin(SA) recombinant fusion proteins which were high-efficiently and solubly expressed in E.
细胞因子-超抗原融合蛋白实际上是代替现有技术的抗体的，也具有靶向作用，是区别于抗体的新的可期待的药物。
The superantigen fusion protein cell factor is actually a substitute for the antigen in the prior art, has a targeting function and is a new prospective medicament different from the antigen.
细胞因子-超抗原融合蛋白实际上是代替现有技术的抗体的，也具有靶向作用，是区别于抗体的新的可期待的药物。
The superantigen fusion protein cell factor is actually a substitute for the antigen in the prior art, has a targeting function and is a new prospective medicament different from the antigen.
应用推荐